17 th International congress on MDS:

Characterization of transcriptional alterations leading to aberrant myeloid differentiation in myelodysplastic syndromes.

Díaz-mazkiaran A De La Fuente J, Serrano G, Ainciburu M, Garcia-olloqui P, Berastegui N, Alfonso A, Vilas-zornoza A, San Martin P, Lamo-espinosa Jm, San Julián M, Acha P, Jimenez T, López F, Molero A, Montoro Mj, Solé F, Díez-campelo M, Valcarcel D, Prósper F, Hernaez M, Ezponda T.»

EHA 2023:

Desarrollo de nuevos modelos predictivos y pronósticos en base al análisis de datos de pacientes con SMD utilizando herramientas de inteligencia artificial.

Adrián Mosquera

Retrospective study of lenalidomide discontinuation in patients with myelodysplastic syndrome harboring del(5q). A Harmony Alliance study

Elena Crisà, Maria Diez Campelo, Ulrich Germing, Elvira Mora Casterà, F.Hernandez Mohedo, Andrea Kündgen, Ebeling Freja, Mikko Myllymäki, Martin Jädersten, Eva Hellstrom-lindberg, Detlef Haase, Giuseppe Pietrantuono, Marco Cerrano, Chiara Frairia, Antonella Poloni, Rosanna Ciancia, Carlo Finelli, Claudio Fozza, Daniela Barraco, Anna Calvisi, Monica Crugnola, Isabella Capodanno, Wolf-Karsten Hofmann, Axel Rüfer, Cecile Bally, Pierre Fenaux, Guillermo Sanz, Valeria Santini